INTRODUCTION
============

Anxious depression is a subtype of depression that is well known to have different neurobiological characteristics.[@B1] Anxious depression generally shows poorer clinical course[@B2] and treatment response,[@B3][@B4] and higher suicide risk[@B2][@B5] than non-anxious depression.

Chronic systemic inflammation is increasingly considered one of the important biological mechanisms of depression. Immune system alteration in depression has been consistently documented. Several studies have reported an alteration in white blood cell (WBC) subset counts[@B6][@B7][@B8] and increased proinflammatory cytokines, including IL-6 and TNF-α, in individuals with depression.[@B9] Recent studies showed that a high inflammatory state can induce *de novo* depression,[@B10] and cytokine infusion induces depression-like symptoms in humans.[@B11] Furthermore, anti-inflammatory agents seem to have a beneficial effect on depression,[@B12] and increased inflammation can worsen prognosis.[@B13]

Previous studies on the inflammatory system in depression have mainly focused on pro-inflammatory cytokines, including IL-6 and TNF-α. WBC subset fraction and counts also provide indirect evidence of an altered inflammatory system in anxious depression. A few reports suggested that severe depression is accompanied by disturbances in total white blood cell counts (i.e., leukocytosis) and leukocyte subset (i.e., neutrophilia, monocytosis, lymphopenia) counts.[@B6][@B7]

Each WBC subset plays a different role in inflammation. Neutrophils are an essential part of the innate immune system and play a major role as phagocytes in acute bacterial or viral inflammation. Lymphocytes comprise 3 different immune cells, i.e., natural killer (NK) cells, T cell, and B cell and mainly work in recruiting humoral immune responses. Eosinophils are mainly associated with parasitic infection and allergic reaction. Basophils are mainly involved in hypersensitivity and anaphylactic reaction. Monocytes also function as phagocytes, but live longer than neutrophils.

Given that anxious depression is associated with a chronic course and poor response to treatment, the altered immune system might be one of the important factors that explain treatment resistance in anxious depression. However, altered blood cell counts in anxious depression have not been previously investigated.

In this exploratory study examining the immune systems in anxious depression, we aimed to characterize the relationship between WBC subset counts and anxiety, in individuals with major depressive disorder (MDD).

METHODS
=======

Subjects
--------

A total of 709 patients newly diagnosed with MDD by the diagnostic criteria of the DSM-IV, were recruited from the outpatient clinic of the Department of Psychiatry and Depression Center of the Samsung Medical Center between July 1, 2009 and July 28, 2012. We only included medically stable subjects who did not require any acute medical interventions. Those who had other axis I psychiatric disorders, including organic mental disorders, mental retardation, neurologic illness including epilepsy, and serious medical illnesses were excluded. Subjects were allowed to take regular mediations to treat non-severe chronic medical conditions including hypertension, diabetes and dyslipidemia as well as psychiatric conditions.

Detailed recruitment and evaluation procedures were described elsewhere.[@B14] Briefly, psychiatrists with \>3 years of clinical experience evaluated the participants\' psychiatric and medical histories, and confirmed their eligibility. A trained psychologist blinded to the psychiatrists\' judgment separately explored the participants\' psychiatric diagnoses and current mood states. Subjects\' diagnoses were evaluated using the Korean version of the Mini International Neuropsychiatric Interview\'s (MINI).[@B15] Cohen\'s kappa values, a measure of the interrater reliability, have ranged from 0.22 to 0.93 in the Korean version of the MINI.[@B16] The severity of depression was measured with the HAM-D. The MDQ and the HCL-32 were used for evaluating potential bipolarity. All study procedures were approved by the Institutional Review Board of the Samsung Medical Center.

Measure of anxiety
------------------

Levels of anxiety was measured using the Anxiety/ Somatization subitem of the Hamilton Depression Rating Scale (HAM-D).[@B17] The Anxiety/Somatization factor of the HAM-D includes the following 6 items: anxiety (psychic), anxiety (somatic), somatic symptoms (gastrointestinal), somatic symptoms (general), hypochondriasis, and insight. Previous studies have used the sum of the anxiety/somatization factor score ≥7 as the cut-off score for anxious depression.[@B18] We regarded anxiety as either a dichotomous variable (i.e., presence of anxious depression) using the definition of anxious depression, or a continuous variable using the HAM-D anxiety/somatization factor total score, or individual item scores. (i.e., psychological anxiety, physical anxiety, gastrointestinal somatic symptoms, general somatic symptoms, hypochondriasis and insight).

Blood sample collection and testing
-----------------------------------

Peripheral blood samples were drawn into EDTA-anticoagulated vacutainer tubes. Complete cell counts were performed on the Sysmex XE2100 automated hematology analyzer (Sysmex Corporation, Kobe, Japan) within 4 hours of collection. The instrument generates differential counts of white blood cells by using multichannel analyses. Specifically, basophils are differentially counted from other granulocytes in a basophil channel by forward and side scattered light information based on their nature of resistance to acidic stripping of the cytoplasm by a specific lysing reagent.

Statistical analysis
--------------------

The demographic data and blood cell counts were compared between individuals with anxious depression and non-anxious depression. Parametric variables were compared by the Student\'s t-test. Categorical data were analyzed by the chi-square test.

We used 3 different approaches to determine associations between WBC subsets and anxiety in depression. First, we regarded anxiety as a continuous variable, and performed correlation analyses with each WBC subset. Each item and the sum of the anxiety/somatization factors of the HAM-D were used as variables. Pearson\'s correlation analyses were done to determine the relationship between anxiety and WBC subset fractions. Second, we defined anxious depression as a HAM-D anxiety/somatization factor score ≥7.[@B18] Analysis of Covariance (ANCOVA) was performed to compare WBC subset fractions between individuals with anxious and non-anxious depression, after adjusting for age, sex and duration of education. Third, we performed linear regression analyses and logistic regression analyses to determine the effects of WBC subset counts on anxiety. We used raw counts of each subset in regression models, in order to include various WBC subsets in one model. Age and sex were additionally entered as covariates.

The null hypothesis was rejected at p\<0.05. The SPSS 17.0. statistical package was used for the analyses.

RESULTS
=======

Of the 709 individuals with MDD, 302 (42.6%) were classified as having anxious depression. There were no significant differences in socio-demographic characteristics between individual with anxious and non-anxious depression ([Table 1](#T1){ref-type="table"}).

As expected, subjects with anxious depression had higher total HAM-D scores compared to those with non-anxious depression. Individuals with anxious depression showed a significantly higher percentage of segmented neutrophils and lower percentage of basophils as compared to those with non-anxious depression ([Table 2](#T2){ref-type="table"}). No other differences in cell counts were detected between the 2 groups.

The correlation analysis ([Table 3](#T3){ref-type="table"}) indicated that eosinophil and basophil counts were negatively correlated with HAM-D anxiety/somatization factor scores (eosinophil: r=-0.075, p=0.046; basophil: r=-0.092, p=0.014). The individual items of HAM-D anxiety/somatization factors i.e., psychological anxiety, somatic complaints and hypochondriasis also showed significant negative correlation with eosinophil counts; psychological anxiety showed significant negative correlation with the basophil count. Total HAM-D scores did not show any significant association with blood cell counts.

ANCOVA analyses revealed that individuals with anxious depression had lower percentages of basophils and lymphocytes, and a higher percentage of segmented neutrophils compared to those with non-anxious depression after adjusting for age, sex and duration of education.

When the HAM-D anxiety/somatization sum scores were used as a dependent variable in a linear regression model, the model was not statistically significant (F=1.79; p=0.086). Logistic regression analysis using the presence of anxious depression as a dependent variable indicated that the model was not statistically significant (χ^2^=12.26; p=0.092). However, when an anxiety score (a sum of somatic and psychic anxiety) was entered as a dependent variable, the model was statistically significant (F=2.16; p=0.036), and basophil counts showed a negative association with the anxiety scores, after adjusting for all other WBC subset counts and demographic factors (t=-2.57; p=0.010) ([Table 4](#T4){ref-type="table"}).

DISCUSSION
==========

This is the first study to investigate the relationship between basophil counts and the presence of co-morbid anxiety in MDD patients. We demonstrated differences in WBC subset fractions between anxious and non-anxious depression. Especially, analyses conducted showed that venous blood basophil counts were reduced in anxious depression vs. non-anxious depression. In fact, we found that such counts were inversely associated with anxiety severity, as measured by the anxiety/somatization subscaleof the HAM-D. Fractions of segmented neutrophils and lymphocytes also showed significant differences between anxious and non-anxious depression after adjusting for demographic factors.

Basophils are circulating blood granulocytes that comprise roughly 0.1--0.3% of all circulating WBCs. Basophils have abundant immunoglobulin E (IgE) receptors and histamine, and are mainly involved in mediating allergic reactions, including hypersensitivity reactions and anaphylaxis. Such reactions involve the release of histamine and major proinflammatory cytokines, including IL-6, on activation.[@B19] In addition, basophils share a hematopoitetic lineage with tissue-dwelling mast cells, which also play an important role in the inflammatory reaction. For instance, both basophils and mast cells contain abundant heparin and histamine.[@B20] Interestingly enough, allergic diseases, such as atopic dermatitis and asthma, are known to be associated with depression.[@B21][@B22] Psychological stress can activate the hypothalamic-pituitary-adrenal axis[@B23] and the sympathoadrenal medullary system.[@B24] Catecholamines and cortisol generated by both activated systems increase allergic inflammatory responses.[@B25] Nerve terminals in cutaneous sensory nerves release neuropeptides,[@B26] which eventually activate mast cells, which further release proinflammatory mediators.[@B27] Interestingly, the mast cell is known to play a major role in the central nervous system (CNS) neuroinflammation.[@B28]

Basophils mainly release histamine in allergic reactions. The histamine system plays an important role in modulating alertness, anxiety, memory and mood.[@B29] Mirtazapine and tricyclic antidepressants act on the histamine receptor directly, and are effective in decreasing anxiety.[@B30] A recent animal study showed that histamine was released from the brain mast cell.[@B31] Alteration in the histaminergic system may be involved in the development of anxious depression which may be associated with poor clinical course. Findings from our study may reflect the association between inflammation related to allergic reaction and anxious depression. Decreased basophil counts could affect histamine release and eventually increase the individuals\' anxiety level. Further study of associated neuroinflammatory substances is required to confirm our findings.

In addition to decreased basophils, individuals with anxious depression in our study showed an increased percentage of segmented neutrophils. Maes et al.[@B6] in a study on WBC counts and depression, reported monocytosis and neutrophilia in individuals with depression compared to healthy individuals; while McAdams and Leonard[@B7] reported increased neutrophils and decreased monocytes. Increased cellular immunity may also be involved in poor clinical course and treatment responses.

Our findings need to be interpreted within the context of the study design. First, this was a cross-sectional study and WBC subset counts were evaluated only once. Second, we could not get detailed medical history, including current medication or certain medical conditions that may have affected the variation in WBC subset counts. We excluded all subjects who required acute medical intervention, including morbid obesity, in order to minimize the confounding effect of the subjects\' medical condition. Third, peripheral WBC subset counts may not reflect the central inflammatory system. Fourth, we did not include non-depressed, healthy subjects in our study samples.

Despite these limitations, this study showed that there were differences in the basophil fraction and count between anxious and non-anxious depression. Basophils are associated with allergic reactions, the latter of which is also biologically associated with anxiety and depression. Further studies are required to confirm the findings from this work.
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###### Socio-demographic characteristics of the subjects with major depressive disorder (N=709)
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Anxiety/somatization factor score of the HAM-D ≥7 as cut-off score for anxious depression. HAM-D: Hamilton depression rating scale

###### Peripheral blood cell counts of the subjects with major depressive disorder (N=709)
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RBC: red blood cell, WBC: white blood cell

###### Correlation analysis between peripheral blood cell counts and anxiety evaluated using HAM-D
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Pearson\'s correlation coefficients were presented. ^\*^p\<0.05, ^\*\*^p\<0.01. HAM-D: Hamilton Depression Rating Scale, WBC: white blood cell, RBC: red blood cell

###### Linear regression analysis with the HAM-D anxiety scores (sum of psychic anxiety and somatic anxiety) as a dependent variable
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Each white blood cell subset was entered using raw count. HAM-D: the Hamilton Depression Rating Scale
